NEXMED INC
10QSB, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: NEXMED INC, 10QSB, 2000-08-11
Next: QC OPTICS INC, 10QSB, 2000-08-11



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      16,743,070
<SECURITIES>                                   714,994
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            18,147,871
<PP&E>                                         815,275
<DEPRECIATION>                               (203,172)
<TOTAL-ASSETS>                              18,759,974
<CURRENT-LIABILITIES>                          318,229
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        21,747
<OTHER-SE>                                  18,419,998
<TOTAL-LIABILITY-AND-EQUITY>                18,441,745
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             4,023,225
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             272,517
<INCOME-PRETAX>                            (3,707,438)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,707,438)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,707,438)
<EPS-BASIC>                                     (0.19)
<EPS-DILUTED>                                   (0.19)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission